October 2025
1. RAHIMOV F, Jacobs BM, Lee JS, Mahi NA, et al
   Common Diseases in Clinical Cohorts - Not Always What They Seem.
   N Engl J Med. 2025;393:1589-1598.
   

   >> Share

   
   May 2025
2. CALABRESI PA
   Progress toward Mitigating Disability Progression in Multiple Sclerosis.
   N Engl J Med. 2025;392:1966-1968.
   

   >> Share

   
   April 2025
3. FOX RJ, Bar-Or A, Traboulsee A, Oreja-Guevara C, et al
   Tolebrutinib in Nonrelapsing Secondary Progressive Multiple Sclerosis.
   N Engl J Med. 2025 Apr 8. doi: 10.1056/NEJMoa2415988.
   

   >> Share

   
   
4. OH J, Arnold DL, Cree BAC, Ionete C, et al
   Tolebrutinib versus Teriflunomide in Relapsing Multiple Sclerosis.
   N Engl J Med. 2025 Apr 8. doi: 10.1056/NEJMoa2415985.
   

   >> Share

   
   February 2024
5. HAUSER SL
   Silencing Immune Dialogue in Multiple Sclerosis.
   N Engl J Med. 2024;390:662-663.
   

   >> Share

   
   
6. VERMERSCH P, Granziera C, Mao-Draayer Y, Cutter G, et al
   Inhibition of CD40L with Frexalimab in Multiple Sclerosis.
   N Engl J Med. 2024;390:589-600.
   

   >> Share

   
   June 2023
7. LEE CD, Galetta SL, Dobson R
   Management of Possible Multiple Sclerosis.
   N Engl J Med. 2023;388:2195-2198.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share